The state of Georgia currently has 27 active clinical trials seeking participants for Asthma research studies. These trials are conducted in various cities, including Atlanta, Augusta, Decatur and Savannah.
An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)
NCT05243680
Recruiting
The purpose of this open-label 12-month extension study is to continue to characterize the long-term safety, efficacy and immunogenic profile of GSK3511294 (Depemokimab) in participants with severe asthma with an eosinophilic phenotype following completion of clinical studies 206713 or 213744.
Gender:
All
Ages:
12 years and above
Trial Updated:
10/13/2023
Locations: GSK Investigational Site, Adairsville, Georgia +1 locations
Conditions: Asthma
Register for Updates
Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma
NCT05035862
Recruiting
This study is a two strata, dose escalation Phase I clinical trial designed to assess the safety and determine the maximal tolerated dose (MTD) of allogenic cord tissue derived MSCs (cMSCs, stratum 1) and allogeneic, interferon-γ primed bone marrow MSCs (γMSCs, stratum 2). Each stratum is designed to independently accrue 3 children at a dose level 1 of 2x106 cells/kg and 6 children at dose level 2 of 10x106 cells/kg, resulting in 9 children in each stratum. The primary objectives are to determin... Read More
Gender:
All
Ages:
Between 18 years and 30 years
Trial Updated:
08/23/2023
Locations: Children's Healthcare of Atlanta, Atlanta, Georgia
Conditions: Asthma
Register for Updates
Symptom Clusters in Children With Exacerbation-prone Asthma
NCT04002362
Recruiting
Pediatric participants with exacerbation-prone asthma will receive an intramuscular injection of triamcinolone acetonide and will be followed for 48 weeks. The study visit 2 weeks after the injection will assess the response to the study medication, while the remaining study visits will examine the temporal stability of the symptom clusters.
Gender:
All
Ages:
Between 6 years and 21 years
Trial Updated:
05/08/2023
Locations: Children's Healthcare of Altanta, Atlanta, Georgia +1 locations
Conditions: Asthma in Children
Register for Updates